Tata1mg - Dose Daily : Pharma News | Latest Pharmaceutical News, Research & Updates

Dose Daily News is your trusted source for the latest updates in healthcare and pharmaceuticals. We deliver clear, reliable, and timely news to keep you informed and ahead in the world of health and medicine.

Latest news

Novo Nordisk Hit by an IT Security Breach: Pharma Giant Confronts Cyber Threats

Breaking News June 15, 2026 0

Novo Nordisk (Novo Nordisk A/S) the Danish multinational pharmaceutical major, earlier this week announced that the...

Hair Color Brands Must Meet New CDSCO Regulations Under Latest Order

Breaking News June 14, 2026 0

The Central Drugs Standard Control Organisation (CDSCO), under the...

FDA Grants Accelerated Approval to Sanofi’s Tzield® for Pediatric Stage 3 Type 1 Diabetes

Breaking News June 14, 2026 0

The U.S. Food and Drug Administration has granted accelerated...

Investors Show Strong Interest in Hexagon Nutrition IPO, Bids Reach 54 Times

Breaking News June 12, 2026 0

Hexagon Nutrition Limited, a leading research-driven nutrition company, concluded...

Johnson & Johnson to acquire Firefly Bio to advance novel cancer treatment

Breaking News June 13, 2026 0

Johnson & Johnson announced that it has entered into...

ICMR Study Focuses on Vitamin Intake and Diet Diversity

Breaking News June 11, 2026 0

A groundbreaking community-based study conducted by the ICMR-National Institute...

Tag: Tata1mg

Hair Color Brands Must Meet New CDSCO Regulations Under Latest Order

FDA Grants Accelerated Approval to Sanofi’s Tzield® for Pediatric Stage 3 Type 1 Diabetes

The FDA has outlined its updated strategy for generic drug oversight

Orionis Biosciences Announces $1.44B Strategic Collaboration with Novartis to Discover and Develop Molecular Glue Medicines

Dr. Sharadwat Mukherjee Takes Charge as West Bengal Health Minister, Sets Vision for Modern, Equitable Healthcare

Follow us

Categories

Latest news

Novo Nordisk Hit by an IT Security Breach: Pharma Giant Confronts Cyber Threats

Hair Color Brands Must Meet New CDSCO Regulations Under Latest Order

FDA Grants Accelerated Approval to Sanofi’s Tzield® for Pediatric Stage 3 Type 1 Diabetes

Popular news

Investors Show Strong Interest in Hexagon Nutrition IPO, Bids Reach 54 Times

Johnson & Johnson to acquire Firefly Bio to advance novel cancer treatment

ICMR Study Focuses on Vitamin Intake and Diet Diversity